AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16569797
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium delayed-release (DR)
Trial: 16569797
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium extended-release (ER)
Trial: 8721265
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (160 mg/d)
Trial: 1551152
Drug: Rectal ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal ibuprofen (40 mg.kg‐1.day‐1 in divided doses)
Trial: 31233117
Drug: Direct-acting antivirals
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting antivirals (DAAs) in primary care
Trial: 29688793
Drug: High-dose BNR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose BNR (BNR-H, 1010 CFU/day)
Trial: 29688793
Drug: Low-dose BNR
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose BNR (BNR-L, 109 CFU/day)
Trial: 26456200
Drug: Intra-arterial therapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial therapy (IA therapy)
Trial: 24866496
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose resveratrol (300mg/day)
Trial: 24866496
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose resveratrol (1000mg/day)
Trial: 15813664
Drug: Albuterol HFA
RxNorm normalized name: Albuterol Sulfate 0.09 MG/1 ACTUATION Inhalation Aerosol Powder [ALBUTEROL HFA]
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol HFA (Ventoline) 2 x 100microg
Trial: 1646240
Drug: Fosinopril sodium
RxNorm normalized name: Fosinopril Sodium
DrugBank: Fosinopril (DB00492)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosinopril sodium (SQ 28,555) 10 to 640 mg once daily for 3 days
Trial: 1646240
Drug: Fosinopril sodium
RxNorm normalized name: Fosinopril Sodium
DrugBank: Fosinopril (DB00492)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosinopril sodium (SQ 28,555) 80 mg bid and 160 mg bid for 2 weeks
Trial: 6274372
Drug: Glycopyrrolate combined
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate combined with antacid
Trial: 6274372
Drug: Atropine combined
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine combined with antacid
Trial: 6274372
Drug: Saline combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline combined with antacid
Trial: 10393682
Drug: Ganciclovir (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (no calcium blockers)
Trial: 10393682
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no calcium blockers)
Trial: 10393682
Drug: Ganciclovir (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (with calcium blockers)
Trial: 10393682
Drug: Placebo (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (with calcium blockers)
Trial: 8707991
Drug: Basic oral
RxNorm normalized name: sodium phosphate, dibasic Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic oral hygiene instructions
Trial: 25679310
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy combined with two cycles of concomitant cisplatin
Trial: 25679310
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy alone
Trial: 23102241
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori eradication therapy (group A, n = 261)
Trial: 17907485
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with Clearfil New Bond adhesive
Trial: 10753983
Drug: Warfarin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (2 mg)
Trial: 10753983
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1 mg warfarin plus 300 mg aspirin
Trial: 10753983
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2 mg warfarin plus 300 mg aspirin
Trial: 30813694
Drug: Butylphthalide treatment
RxNorm normalized name: Butylphthalide
DrugBank: Butylphthalide (DB12749)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butylphthalide treatment group
Trial: 22514730
Drug: Sulfadoxine‐pyrimethamine (SP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine‐pyrimethamine (SP) administered early (4 months of gestation)
Trial: 22514730
Drug: Sulfadoxine‐pyrimethamine (SP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine‐pyrimethamine (SP) administered late (6-7 months of gestation)
Trial: 12766522
Drug: Antiarrhythmic drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drug therapy (e.g., amiodarone)
Trial: 10667832
Drug: Dexibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexibuprofen 200 mg t.i.d.
Trial: 3906995
Drug: D-penicillamine (large
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (large and mean doses)
Trial: 3906995
Drug: Nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiinflammatory drugs (NAID)
Trial: 30578651
Drug: inspiratory resistance
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: inspiratory resistance (RES) of ∼5 cmH2O L−1 s−1
Trial: 24812899
Drug: Ningdong Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ningdong Granule (NG), one dose daily for 3 months, dissolved in boiled water, taken in two portions in the morning and evening.
Trial: 24812899
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with NG and Tiapride, equal doses for 3 months.
Trial: 24812899
Drug: Tiapride Tablet,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapride Tablet, 50-100 mg twice daily for 3 months, max dosage 300 mg per day.
Trial: 18204271
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (LPI)
Trial: 18204271
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (RGI)
Trial: 11379380
Drug: Continuous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous estradiol 50 micrograms/24 h with vaginal progesterone gel 8 mg every 2nd day
Trial: 11379380
Drug: Continuous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous estradiol 50 micrograms/24 h with medroxyprogesterone acetate 5 mg/day orally during 12 days per month
Trial: 9404445
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment (250 mg testosterone enanthate/month for four months)
Trial: 25049329
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (IC) followed by chemoradiotherapy (CRT) - docetaxel 75 mg/m² on day 1, cisplatin 75 mg/m² on day 1, fluorouracil 750 mg/m² on days 1 to 5, followed by CRT (docetaxel, fluorouracil, hydroxyurea plus radiotherapy 0.15 Gy twice per day every other week)
Trial: 25049329
Drug: Chemoradiotherapy (CRT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiotherapy (CRT) alone - docetaxel, fluorouracil, and hydroxyurea plus radiotherapy 0.15 Gy twice per day every other week
Trial: 20083373
Drug: Paracetamol (acetaminophen)
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol (acetaminophen) 4 g daily
Trial: 19226897
Drug: Visceral differentiation-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visceral differentiation-based acupuncture therapy
Trial: 7489976
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (12 g daily for 2 months)
Trial: 7489976
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (12 g daily for 2 months)
Trial: 30904595
Drug: Ranibizumab 0.3
RxNorm normalized name: RANIBIZUMAB 0.3MG/0.05ML INJ,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 0.3 mg PRN
Trial: 25127405
Drug: NRT (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRT (15 mg/16 h transdermal patches)
Trial: 16050054
Drug: Omega-3 FA
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 FA + policosanol 5 mg/day
Trial: 16050054
Drug: Omega-3 FA
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 FA + policosanol 10 mg/day
Trial: 14624217
Drug: Other coagulation
RxNorm normalized name: Coagulation factor XIa
DrugBank: Coagulation factor XIa (DB15420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other coagulation modulators
Trial: 11221091
Drug: ROM plus
RxNorm normalized name: Ascorbic Acid/Biotin/Boron/Calcium/Calcium Pantothenate/Chloride/Chromium/Copper/Cyanocobalamin/Folic Acid/Iodine/Iron/Lutein/Magnesium/Manganese/Molybdenum/Niacin/Nickel/Phosphorus/Phytonadione/Potassium/Pyridoxine/Riboflavin/Selenium/Silicon Dioxide/Thiamine/Tin/Vanadium/Vitamin A/Vitamin D/Vitamin E/Zinc 60 MG-0.03 MG-0.15 MG-162 MG-10 MG-72 MG-0.12 MG-2 MG-0.006 MG-0.4 MG-0.15 MG-18 MG-0.25 MG-100 MG-2 MG-0.075 MG-20 MG-0.005 MG-109 MG-0.025 MG-80 MG-2 MG-1.7 MG-0.02 MG-2 MG-1.5 MG-0.01 MG-0.01 MG-5000 IU-400 IU-30 IU-15 MG Oral Tablet [VANTROM PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROM plus low-dose Convit vaccine
Trial: 11221091
Drug: Single-dose ROM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose ROM therapy
Trial: 8971431
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg controlled-release (CR) oxycodone tablets
Trial: 8971431
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg immediate-release (IR) oxycodone oral solution
Trial: 1732652
Drug: 720 mL/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 720 mL/d of caffeinated coffee
Trial: 23823716
Drug: Cocoa product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa product rich in fibre (15 g each, 2 servings daily for 4 weeks)
Trial: 22167566
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal with 25 mg preladenant
Trial: 22167566
Drug: Fasting with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting with 25 mg preladenant
Trial: 20018913
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment using intermittent ATRA
Trial: 20018913
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment using continuous 6 mercaptopurine plus methotrexate
Trial: 20018913
Drug: Both maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both maintenance treatments
Trial: 15801944
Drug: Raloxifene 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 120 mg in males with renal impairment
Trial: 15801944
Drug: Raloxifene 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 120 mg in healthy males
Trial: 12162932
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (lovastatin, pravastatin, simvastatin)
Trial: 9602956
Drug: 300-mg irbesartan
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300-mg irbesartan tablet under fasted conditions
Trial: 9602956
Drug: 300-mg irbesartan
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300-mg irbesartan tablet 5 minutes after a high-fat breakfast
Trial: 29542371
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ketamine
Trial: 29542371
Drug: 4.5 mg
RxNorm normalized name: phenol 14.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 mg midazolam
Trial: 26902307
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg single-dose albendazole administration
Trial: 26902307
Drug: 60000 μg
RxNorm normalized name: penicillin G potassium 60000 UNT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60000 μg vitamin A capsule combined with 400 mg single-dose albendazole
Trial: 22316635
Drug: Pardoprunox (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pardoprunox (up to 42 mg/day)
Trial: 20110117
Drug: 8 IU/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 IU/kg of botulinum toxin A injected into the detrusor muscle and 2 IU/kg through 4 injections in external urethral sphincter (Group B)
Trial: 9862558
Drug: Phenelzine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenelzine therapy
Trial: 9862558
Drug: Pill placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill placebo administration
Trial: 9862558
Drug: Educational-supportive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational-supportive group therapy
Trial: 7695309
Drug: Rufloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rufloxacin 400 mg single dose
Trial: 7695309
Drug: Pefloxacin 800
RxNorm normalized name: pefloxacin
DrugBank: Pefloxacin (DB00487)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin 800 mg single dose
Trial: 827989
Drug: Preoperative antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative antibiotic administration
Trial: 827989
Drug: Postoperative antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative antibiotic administration
Trial: 31611038
Drug: tesamorelin 2
RxNorm normalized name: tesamorelin 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tesamorelin 2 mg once daily for 12 months
Trial: 31611038
Drug: placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo once daily for 12 months
Trial: 31611038
Drug: tesamorelin 2
RxNorm normalized name: tesamorelin 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tesamorelin 2 mg once daily
Trial: 29053120
Drug: Divaza (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divaza (2 tablets 3 times a day)
Trial: 26323041
Drug: Dopamine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (5-10 μg/kg/min)
Trial: 26323041
Drug: Epinephrine (0.1-0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (0.1-0.3 μg/kg/min)
Trial: 24292818
Drug: Iron-fortified formula
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED CONC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified formula (IFF; 0.8-1.0 mg iron/100 ml)
Trial: 3289769
Drug: Patient-Controlled Epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-Controlled Epidural Analgesia (PCEA) - Group A (n = 14) received a background infusion of 4 ml/hr 0.125% bupivacaine, with self-administered 4 ml aliquots as required (up to 16 ml/hr).
Trial: 3289769
Drug: Continuous Infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Infusion Epidural Analgesia (CIEA) - Group B (n = 11) received a continuous infusion of 12 ml/hr with the demand-button deactivated.
Trial: 21938889
Drug: Traditional Occupational
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Occupational Therapy (TOT)
Trial: 17122578
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml Hemospan
Trial: 17122578
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml Hemospan
Trial: 15322325
Drug: Combined formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined formula consisting of ACEI, AIIRA, CCB, antiplatelet+/−heparin
Trial: 10585174
Drug: Norethisterone acetate
RxNorm normalized name: Norethisterone acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone acetate (NETA; 0.5 mg) alone
Trial: 10585174
Drug: Norethisterone acetate
RxNorm normalized name: Norethisterone acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone acetate (NETA; 0.5 mg) in combination with estradiol (E2; 1 mg)
Trial: 10585174
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.5 mg NETA with 1 mg E2 administered daily for 28 days
Trial: 8901825
Drug: Ramipril and
RxNorm normalized name: ramipril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril and felodipine treatment for 6 months
Trial: 8901825
Drug: Drug washout
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug washout after treatment
Trial: 18235123
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of muramyl tripeptide (MTP) to chemotherapy
Trial: 18235123
Drug: Chemotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy without MTP
Trial: 18235123
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of ifosfamide to chemotherapy
Trial: 10374198
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not receiving thrombolytic agents)
Trial: 8911009
Drug: Intramuscular (i.m.)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (i.m.)
Trial: 8911009
Drug: Subcutaneous (s.c.)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (s.c.)
Trial: 31925799
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral oestradiol-17β 2 mg plus norethisterone acetate 1 mg daily (E2/NETA)
Trial: 29453467
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose magnesium sulfate
Trial: 29453467
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose only magnesium sulfate
Trial: 20726625
Drug: SABA (short-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SABA (short-acting beta-agonists)
Trial: 20726625
Drug: Leukotriene receptor
RxNorm normalized name: Leukotriene receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene receptor antagonists (LTRA)
Trial: 20726625
Drug: Daily LABA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily LABA (salmeterol)
Trial: 20726625
Drug: Daily SABA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily SABA
Trial: 18029469
Drug: 40 mg/d
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/d rosuvastatin
Trial: 7907950
Drug: Taxotere (docetaxel)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Taxotere (docetaxel) intravenous infusion at doses of 70-115 mg/m2 every 3 weeks
Trial: 7907950
Drug: Taxotere (docetaxel)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Taxotere (docetaxel) intravenous infusion
Trial: 3002163
Drug: High fiber
RxNorm normalized name: High Fiber Gummies Soft Chew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fiber diet (27 g/1000 kcal)
Trial: 3002163
Drug: Normal fiber
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal fiber diet (11 g/1000 kcal)
Trial: 23442391
Drug: Probiotics capsules
RxNorm normalized name: Culturelle Probiotics Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics capsules containing > 1x10(9) cfu each of Lactobacillus rhamnosus GG and Bifidobacterium lactis BB‐12 per capsule, administered from 16 weeks gestation until delivery.
Trial: 23442391
Drug: Placebo capsules,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules, administered from 16 weeks gestation until delivery.